Interestingly, part of the benefit of intravenous immunoglobulin (IVIG) therapy relies on ficolin-1 pulldown (reported for Kawasaki disease, the most common form of acquired heart disease in childhood) (44). This evidence concerns the gene FCN1 and Kawasaki disease.